NCT03640195

Brief Summary

This study was designed to investigate the effect of Acupoint stimulation on pain reduction, and fatigue, anxiety and depression and quality of life in Head neck cancer receiving Concurrent Chemoradiotherapy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable head-and-neck-cancer

Timeline
Completed

Started Oct 2016

Shorter than P25 for not_applicable head-and-neck-cancer

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 4, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 4, 2017

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 11, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 21, 2018

Completed
Last Updated

August 21, 2018

Status Verified

May 1, 2018

Enrollment Period

1.2 years

First QC Date

July 11, 2018

Last Update Submit

August 17, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference between the two groups from Baseline in Pain Scores on the Visual Analog Scale at 6 Weeks

    Pain intensity was assessed using visual analogue scales (VAS) , which is a 10-cm continuous line to assess the subjective perception of pain in the case, with a score of 0 on the leftmost end of the line indicating "painless" and 10 points indicating The "most severe pain" and the reliability of pain assessment , and all participants received this linear tool measurement, recording a total of five

    from enrollment to end of treatment at 6 weeks

Secondary Outcomes (3)

  • Difference between the two groups from Baseline in fatigue on Brief Fatigue Inventory at 6 Weeks

    from enrollment to end of treatment at 6 weeks

  • Difference between the two groups from Baseline in Anxiety and depression on Hospital Anxiety and depression scale

    from enrollment to end of treatment at 6 weeks

  • Difference between the two groups from Baseline in quality of life European organization for research and treatment of cancer quality of life questionnaire head and neck 35(EORTC QLQ-H & N 35)

    from enrollment to end of treatment at 6 weeks

Study Arms (2)

Experimental group

EXPERIMENTAL

Transcutaneous nerve electrical stimulation and Auricular acupressure.

Other: Device: Transcutaneous acupoint electrical stimulation and seeds for auricular acupressure

Control group

NO INTERVENTION

without intervention

Interventions

Experimental group received Acupoint stimulation, Transcutaneous acupoint electrical stimulation20 minutes/weeks, once a week for six consecutive weeks. The second part of The Experimental group received Auricular acupressure applied to four acupoints, including shenmen (TF2), mouth (IC6), subcortex (CW2), Occiput (AT3). each point is 1min, 5days/week, 3 times/day.

Experimental group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of head and neck cancer with initial concurrent chemoradiotherapy
  • Must be able to communicate clearly
  • Must be above age 20

You may not qualify if:

  • Previous radiotherapy
  • History of arrhythmia or use of a pacemaker
  • Local swelling or infection over the acupoint area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Chou YH, Yeh ML, Huang TS, Hsu H. Acupoint stimulation improves pain and quality of life in head and neck cancer patients with chemoradiotherapy: A randomized controlled trial. Asia Pac J Oncol Nurs. 2021 Dec 25;9(1):61-68. doi: 10.1016/j.apjon.2021.11.002. eCollection 2022 Jan.

MeSH Terms

Conditions

Head and Neck Neoplasms

Interventions

Seeds

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasms

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Intervention is divided into two parts: part of The Experimental group received Transcutaneous acupoint electrical stimulation 20 minutes/weeks, the acupoints are unilateral Hegu (LI4) and LU7; This study used Transcutaneous nerve electrical stimulation , 20 minutes each time, once a week for six consecutive weeks. The second part of The Experimental group received Auricular acupressure applied to four acupoints, including shenmen (TF2), mouth (IC6), subcortex (CW2), Occiput (AT3).A seeds embedding method with seeds attached to the four sides of the unilateral ear, using the thumb and forefinger to apply pressure, the participants will feel sour, each point is 1min, 5days/week, 3 times/day. Control group: without intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2018

First Posted

August 21, 2018

Study Start

October 1, 2016

Primary Completion

December 4, 2017

Study Completion

December 4, 2017

Last Updated

August 21, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share